TY  - JOUR

T1  - The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.

JO  - Health technology assessment (Winchester, England)

PY  - 2006/11/01

AU  - Pandor A

AU  - Eggington S

AU  - Paisley S

AU  - Tappenden P

AU  - Sutcliffe P

ED  - 

VL  - 10

IS  - 41

Y2  - 2024/12/22

ER  -